Macrocyclic peptides active against the hepatitis C virus
申请人:Boehringer Ingelheim (Canada) Ltd.
公开号:US20040002448A1
公开(公告)日:2004-01-01
The present invention covers macrocyclic compounds of formula I active in-vitro and in cellular assays against the NS3 protease of the hepatitis C virus.
1
wherein W, R
21
, R
22
, R
3
, R
4
, D and A are as defined herein, or a pharmaceutically acceptable salt or ester thereof.